Groves C E, Morales M, Wright S H
Department of Physiological Sciences, College of Veterinary Medicine, University of Florida, Gainesville, USA.
J Pharmacol Exp Ther. 1998 Mar;284(3):943-8.
The transport of the nephrotoxic mycotoxin ochratoxin A across the renal peritubular membrane was examined in suspensions of rabbit renal proximal tubules. Ochratoxin A transport across the peritubular membrane was a high-affinity, low-capacity carrier-mediated process with a Jmax value of 0.12 +/- 0.4 nmol/mg of protein/min and a Km value of 1.4 +/- 0.1 microM. The apparent Michaelis constants for inhibition of [3H]para-aminohippurate (PAH) uptake by ochratoxin A inhibition was 1.5 microM, which is similar to the Km value for ochratoxin A uptake in tubule suspensions and suggests that ochratoxin A could be a substrate for the organic anion pathway. The capacity and affinity for peritubular ochratoxin A transport were 40-fold lower and > 100-fold greater, respectively, than those measured for the peritubular uptake of [3H]PAH in tubule suspensions. A concentration of 2.5 mM PAH, which reduced the uptake of [3H]PAH by 90%, reduced ochratoxin A uptake by only 40% to 50%, whereas probenecid concentrations of 0.6 to 2 mM reduced ochratoxin A accumulation in tubule suspensions up to approximately 80% to 90%. This probenecid-sensitive, PAH-insensitive uptake of ochratoxin A suggested that at least one mediated pathway other than the organic anion transporter was involved in the peritubular uptake of this mycotoxin. A 2 mM concentration of the fatty acid octanoate and 1.5 mM concentration of the nonsteroidal anti-inflammatory agent piroxicam were as effective as probenecid in blocking ochratoxin A uptake. The apparent Ki values for inhibition of ochratoxin A uptake by probenecid, piroxicam and octanoate were 30.5 +/- 7.9, 23.2 +/- 10.4 and 81.5 +/- 8.7 microM, respectively. The ability of octanoic acid to inhibit ochratoxin A transport to the same extent as probenecid and a greater extent than PAH suggests that a separate fatty acid transport pathway may be involved in the accumulation of ochratoxin A by suspensions of rabbit renal proximal tubules.
在兔肾近端小管悬浮液中研究了肾毒性霉菌毒素赭曲霉毒素A跨肾小管周围膜的转运。赭曲霉毒素A跨肾小管周围膜的转运是一个高亲和力、低容量的载体介导过程,其Jmax值为0.12±0.4 nmol/毫克蛋白质/分钟,Km值为1.4±0.1 microM。赭曲霉毒素A抑制[3H]对氨基马尿酸(PAH)摄取的表观米氏常数为1.5 microM,这与小管悬浮液中赭曲霉毒素A摄取的Km值相似,表明赭曲霉毒素A可能是有机阴离子途径的底物。肾小管周围赭曲霉毒素A转运的容量和亲和力分别比小管悬浮液中[3H]PAH肾小管周围摄取的测量值低40倍和高100倍以上。2.5 mM的PAH浓度可使[3H]PAH的摄取减少90%,但仅使赭曲霉毒素A的摄取减少40%至50%,而0.6至2 mM的丙磺舒浓度可使小管悬浮液中赭曲霉毒素A的积累减少约80%至90%。这种对丙磺舒敏感、对PAH不敏感的赭曲霉毒素A摄取表明,除了有机阴离子转运体之外,至少还有一条介导途径参与了这种霉菌毒素的肾小管周围摄取。2 mM浓度的脂肪酸辛酸和1.5 mM浓度的非甾体抗炎药吡罗昔康在阻断赭曲霉毒素A摄取方面与丙磺舒一样有效。丙磺舒、吡罗昔康和辛酸抑制赭曲霉毒素A摄取的表观Ki值分别为30.5±7.9、23.2±10.4和81.5±8.7 microM。辛酸抑制赭曲霉毒素A转运的能力与丙磺舒相同且比PAH更强,这表明一条独立的脂肪酸转运途径可能参与了兔肾近端小管悬浮液对赭曲霉毒素A的积累。